Benzenamine, 4,4'-sulfonylbis- | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Benzenamine, 4,4'-sulfonylbis-

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

19 API Suppliers, 15 USDMF, 3 CEP/COS, 6 EU WC, 17 NDC API, 8 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

47 FDF Dossiers, 32 FDA Orange Book, 1 Europe, 2 Canada, 4 Australia, 1 South Africa, 7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

GEL;TOPICAL - 7.5%, TABLET;ORAL - 25MG, TABLET;ORAL - 100MG

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 1 DKSH, 3 Faran Shimi Pharmaceutical, 10 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 2 Corel Pharma Chem, 3 DFE Pharma, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 4 Kerry, 2 Lubrizol Life Science Health, 7 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 14 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

34 Fillers, Diluents & Binders, 21 Direct Compression, 18 Disintegrants & Superdisintegrants, 15 Thickeners and Stabilizers, 12 Co-Processed Excipients, 11 Lubricants & Glidants, 10 Solubilizers, 8 Granulation, 7 Topical, 6 Emulsifying Agents, 5 Controlled & Modified Release, 5 Chewable & Orodispersible Aids, 5 Parenteral, 5 Taste Masking, 3 Rheology Modifiers, 3 Coating Systems & Additives, 3 Film Formers & Plasticizers, 2 Surfactant & Foaming Agents, 2 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 28 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 3 Finished Drug Prices, 4 Annual Reports

MARKET PLACE

16 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

$ Xls

Filters

Filters

FILTER :

filter Product Reset all filters

4 All

01 4Aczone

List of Suppliers

Product Main Page

01

Brand Name : Aczone

Duphat

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Dermatology

Currency : USD

2017 Revenue in Millions : 167

2016 Revenue in Millions : 217

Growth (%) : -23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Aczone

Duphat

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Dermatology

Currency : USD

2018 Revenue in Millions : 56

2017 Revenue in Millions : 167

Growth (%) : -67%

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Aczone

Duphat

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Dermatology

Currency : USD

2016 Revenue in Millions : 217

2015 Revenue in Millions : 171

Growth (%) : 27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Aczone

Duphat

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Main Therapeutic Indication : Dermatology

Currency : USD

2019 Revenue in Millions : 9

2018 Revenue in Millions : 56

Growth (%) : -83

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info